Sign in

CIK 0001701108

  • Non-accelerated filer
  • Smaller reporting company

Spero Therapeutics, Inc.

Sign in to watch
Ticker
SPRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-242-1600
Business address
675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
Former names
Spero Therapeutics, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$42,485
in 1 filing

Net −$42,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Rajavelu Esther −$42K Reporting owner sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2019-06-05 Deshpande Milind Director Grant or award · Stock Option (right to buy) +6,073 6,073
2019-06-05 VINK PATRICK V.J.J. Director Grant or award · Stock Option (right to buy) +6,073 6,073
2019-03-29 Smith Cynthia Director Grant or award · Stock Option (right to buy) +12,146 12,146
2019-01-02 Parr Thomas R JR Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +35,000 35,000
2019-01-02 Melnick David A. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +65,000 65,000
2019-01-02 Larkin Cristina Chief Operating Officer Grant or award · Stock Option (Right to Buy) +65,000 65,000
2019-01-02 Sendek Joel Chief Financial Officer Grant or award · Stock Option (Right to Buy +65,000 65,000
2019-01-02 Mahadevia Ankit CEO and President Grant or award · Stock Option (Right to Buy) +180,000 180,000
2018-09-21 Pottage John C Jr Director Grant or award · Stock Option (right to buy) +12,146 12,146
2018-07-17 GLAXOSMITHKLINE PLC 10% owner Purchase +80,000 $12.50 $1.0M 1,934,006
2018-07-06 Mahadevia Ankit Exercise or conversion +1,600 $5.90 $9K 67,417
2018-07-06 Mahadevia Ankit Sale −500 $17.50 $9K 66,917
2018-07-06 Mahadevia Ankit Sale −100 $17.55 $2K 66,817
2018-07-06 Mahadevia Ankit Sale −400 $17.58 $7K 66,417
2018-07-06 Mahadevia Ankit Sale −100 $17.62 $2K 66,317
2018-07-06 Mahadevia Ankit Sale −100 $17.71 $2K 66,217
2018-07-06 Mahadevia Ankit Sale −200 $17.90 $4K 66,017
2018-07-06 Mahadevia Ankit Sale −200 $17.92 $4K 65,817
2018-07-06 Mahadevia Ankit Exercise or conversion · Stock Option (Right to Buy) −1,600 118,888
2018-07-05 Larkin Cristina Chief Operating Officer Exercise or conversion +4,000 $5.90 $24K 5,500

Page 14 of 17 · 340 trades